期刊文献+

巨大盆腔复发性胃肠间质瘤术中大出血的处理 被引量:1

原文传递
导出
摘要 腹膜后肿瘤由于解剖部位特殊和肿瘤的血供特点.术中大出血较为常见。我院于2007年9月在手术切除一巨大盆腔复发性胃肠间质瘤(gastrointestinal stromal tumor.GIST)时,出现了术中大出血,现将处理体会总结如下。
出处 《中华胃肠外科杂志》 CAS 2008年第6期596-596,共1页 Chinese Journal of Gastrointestinal Surgery
  • 相关文献

参考文献3

二级参考文献33

  • 1沈琳,金懋林.甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤[J].中华肿瘤杂志,2004,26(11):697-699. 被引量:27
  • 2I-ShyanSheen,Kuo-ShyangJeng,Shou-ChuanShih,Chih-RoaKao,Wen-HsingChang,Horng-YuanWang,Po-ChuanWang,Tsang-EnWang,Li-RungShyung,Chih-ZenChen.Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(2):187-192. 被引量:41
  • 3宋少柏,王平,梁法启,蒋彦永.累及重要血管的腹膜后肿瘤手术处理经验(附20例报告)[J].中华外科杂志,1995,33(6):342-344. 被引量:21
  • 4Heslin MJ,Lewis JJ,Nadler E,et al.Prognostic factors associated with long-term survival for retroperitoneal sarcoma:implications for management[J].Clin Oncol,1997,15(8):2832.
  • 5Bautista N,Su W,O'Connell TX.Retroperitoneal softtissue sarcomas:prognosis and treatment of primary and recurrent disease[J].Am Surg,2000,66(9):832-836.
  • 6Joensuu H,Fletcher C,Dimitrijevic S,et al.Management of malignant gastrointestinal stromal tumours[J].Lancet Oncol,2002,3(11):655-664.
  • 7DeMatteo RP.The GIST of targeted cancer therapy:A tumor (gastrointestinal stromal tumor),a mutated gene (c-kit),and a molecular inhibitor (STI571)[J].Ann Surg Oncol,2002,9(9):831-839.
  • 8Eilber FC,Rosen G,Forscher C,et al.Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas[J].Ann Surg Oncol,1999,6(7):645-650.
  • 9Karakousis CP,Kontzoglou K,Driscoll DL.Intraperitoneal chemotherapy in disseminated abdominal sarcoma[J].Ann Surg Oncol,1997,4(6):496-498.
  • 10Rajan DK,Soulen MC,Clark TW,et al.Sarcomas metastatic to the liver:response and survival after cisplatin,doxorubicin,mitomycin-C,Ethiodol,and polyvinyl alcohol chemoembolization[J].J Vasc Interv Radiol,2001,12(2):187-193.

共引文献20

同被引文献21

  • 1沈琳,金懋林.甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤[J].中华肿瘤杂志,2004,26(11):697-699. 被引量:27
  • 2蔡国响,蔡三军,师英强,杜春燕,侯英勇,徐烨,廉朋,管祖庆,施达仁.26例胃肠道间质瘤肝转移的临床特征和生存分析[J].中华消化杂志,2005,25(9):521-525. 被引量:27
  • 3Posther KE,Wells SA Jr.The future of surgical research:the role of the American College of Surgeons Oncology Group.Eur J Surg Oncol,2005,31 (6):695 -701.
  • 4Dematteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival.Ann Surg,2000,231 (1):51-58.
  • 5Nunobe S,Sano T,Shimada K,et al.Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointetinal leiomyosarcomas.Jpn J Clin Oncol,2005,35 (6):338-341.
  • 6Blanke CD,Demetri GD,yon Mehren M,et al.Long-term results from a randomized phase Ⅱ trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.J Clin Oncol,2008,26(4):620-625.
  • 7Rutkowski P,Nowecki Z,Nyckowski P,et al.Surgicaltreatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.J Surg Oncol,2006,93(4):304-311.
  • 8Blanke CD,Rankin C,Demetri GD,et al.PhaseⅢ randomized,intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromaltumors expressing the kit receptor tyrosine kinase:S0033.J Clin Oncol,2008,26(4):626-632.
  • 9Casali PG,Verweij J,Kotasek D,et al.Imatinib mesylate in advanced gastrointestinal stromal tumors (GIST):Survival analysis of the intergroup EORTC/ISG/AGITG randomized trial in 946patients.Eur J Cancer,2005,3 Suppl:201-203.
  • 10Gronchi A,Fiore M,Miselli F,et al.Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.Ann Surg,2007,245 (3):341-346.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部